SI2047857T1 - Sredstvo za injiciranje ki vsebuje antibiotik in raztopina za injiciranje ki vsebuje to sredstvo - Google Patents

Sredstvo za injiciranje ki vsebuje antibiotik in raztopina za injiciranje ki vsebuje to sredstvo

Info

Publication number
SI2047857T1
SI2047857T1 SI200730847T SI200730847T SI2047857T1 SI 2047857 T1 SI2047857 T1 SI 2047857T1 SI 200730847 T SI200730847 T SI 200730847T SI 200730847 T SI200730847 T SI 200730847T SI 2047857 T1 SI2047857 T1 SI 2047857T1
Authority
SI
Slovenia
Prior art keywords
injection
agent
wap
solution
composition
Prior art date
Application number
SI200730847T
Other languages
English (en)
Inventor
Hirofumi Nakajima
Haruhiko Machida
Original Assignee
Arigen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arigen Pharmaceuticals Inc filed Critical Arigen Pharmaceuticals Inc
Publication of SI2047857T1 publication Critical patent/SI2047857T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200730847T 2006-06-29 2007-06-28 Sredstvo za injiciranje ki vsebuje antibiotik in raztopina za injiciranje ki vsebuje to sredstvo SI2047857T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006179778 2006-06-29

Publications (1)

Publication Number Publication Date
SI2047857T1 true SI2047857T1 (sl) 2012-03-30

Family

ID=38845613

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730847T SI2047857T1 (sl) 2006-06-29 2007-06-28 Sredstvo za injiciranje ki vsebuje antibiotik in raztopina za injiciranje ki vsebuje to sredstvo

Country Status (17)

Country Link
US (1) US7968588B2 (sl)
EP (1) EP2047857B1 (sl)
JP (1) JP5272126B2 (sl)
KR (1) KR101286038B1 (sl)
CN (1) CN101578103B (sl)
AT (1) ATE539761T1 (sl)
AU (1) AU2007266063B2 (sl)
BR (1) BRPI0713080A2 (sl)
CA (1) CA2656604C (sl)
DK (1) DK2047857T3 (sl)
ES (1) ES2378279T3 (sl)
MX (1) MX2009000155A (sl)
PL (1) PL2047857T3 (sl)
PT (1) PT2047857E (sl)
RU (1) RU2462261C2 (sl)
SI (1) SI2047857T1 (sl)
WO (1) WO2008001849A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101931880A (zh) 2009-06-19 2010-12-29 中兴通讯股份有限公司 一种多媒体广播组播业务动态复用的资源分配方法
JP5878302B2 (ja) * 2010-05-25 2016-03-08 株式会社ゲノム創薬研究所 新規環状ペプチド化合物とその製造方法及び感染症治療薬
JP5878303B2 (ja) * 2010-05-25 2016-03-08 株式会社ゲノム創薬研究所 抗生物質含有画分、その抗生物質及びその抗生物質の製造方法
MX2019006939A (es) * 2016-12-14 2019-09-13 Sk Biopharmaceuticals Co Ltd Preparacion liquida parenteral que comprende compuesto de carbamato.
US10975121B2 (en) 2017-06-24 2021-04-13 Cytogel Pharma, Llc Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
ES2969958T3 (es) * 2017-11-30 2024-05-23 Cytogel Pharma Llc Formulaciones farmacéuticas analgésicas novedosas y usos de las mismas
KR102434276B1 (ko) 2017-12-08 2022-08-18 엘지디스플레이 주식회사 표시장치
CA3103390A1 (en) * 2018-06-13 2019-12-19 Kyoto Biopharmaceuticals, Inc. Enhancement of antibacterial actions of a depsipeptide antibiotic using synergistic amounts of boric acid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3339235B2 (ja) 1994-02-18 2002-10-28 日本メディカルリサーチ株式会社 抗生物質ｗａｐ−８２９４ａ、その製造法及び抗菌剤
HU218351B (hu) * 1995-02-02 2000-08-28 Nippon Medical Research, Inc. WAP-8294A antibiotikumok, eljárás előállításukra, a termelő mikroorganizmus és az antibiotikumokat tartalmazó antibakteriális gyógyszerkészítmények
EP0838225A3 (en) 1996-10-25 1999-03-24 Hiji, Yasutake Aqueous local anesthetic solution
JP4270588B2 (ja) 1996-11-14 2009-06-03 康武 日地 神経毒軽減麻酔剤
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
MXPA01010247A (es) * 1999-04-15 2002-03-27 Lilly Co Eli Composiciones antifungosas de pseudomicina y metodos para su uso.
CA2375829A1 (en) 1999-06-02 2000-12-07 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
JP4074457B2 (ja) 2001-12-20 2008-04-09 田辺三菱製薬株式会社 ヘパリン溶液入りプレフィルドシリンジ製剤およびその製造方法
MXPA04009037A (es) 2002-03-20 2005-01-25 Pharmacia Corp Formulacion de eplerenona de almacenamiento estable.
AUPS188302A0 (en) 2002-04-22 2002-05-30 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
JP2003321364A (ja) * 2002-05-07 2003-11-11 Eisai Co Ltd シクロデキストリンにより可溶化及び安定化された抗腫瘍剤含有組成物
EP1504755A1 (en) 2002-05-13 2005-02-09 Daiichi Pharmaceutical Co., Ltd. Lyophilization product
DE10228049A1 (de) * 2002-06-24 2004-01-15 Merck Patent Gmbh Flüssige Zubereitung enthaltend Oligopeptide
US7361683B2 (en) 2004-11-24 2008-04-22 Yung Shin Pharm. Ind., Co., Ltd Paclitaxel aqueous injection solution and methods for preparing the same

Also Published As

Publication number Publication date
WO2008001849A1 (fr) 2008-01-03
CA2656604C (en) 2014-01-07
EP2047857A4 (en) 2010-05-26
PT2047857E (pt) 2012-03-15
RU2009102803A (ru) 2010-08-10
MX2009000155A (es) 2009-03-25
JPWO2008001849A1 (ja) 2009-11-26
KR20090030317A (ko) 2009-03-24
EP2047857B1 (en) 2012-01-04
JP5272126B2 (ja) 2013-08-28
AU2007266063A1 (en) 2008-01-03
RU2462261C2 (ru) 2012-09-27
ES2378279T3 (es) 2012-04-10
US20090258920A1 (en) 2009-10-15
ATE539761T1 (de) 2012-01-15
PL2047857T3 (pl) 2012-05-31
BRPI0713080A2 (pt) 2012-10-09
KR101286038B1 (ko) 2013-07-19
EP2047857A1 (en) 2009-04-15
DK2047857T3 (da) 2012-02-27
CA2656604A1 (en) 2008-01-03
CN101578103A (zh) 2009-11-11
CN101578103B (zh) 2013-09-25
AU2007266063B2 (en) 2011-09-08
US7968588B2 (en) 2011-06-28

Similar Documents

Publication Publication Date Title
PL2047857T3 (pl) Środek przeznaczony do wstrzykiwania zawierający antybiotyk i roztwór do wstrzykiwania zawierający środek
ECSP077250A (es) Solución para infusión de dihidropteridinonas estabilizada para el almacenamiento
BRPI0611705A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de composto
PT2038290E (pt) Moduladores de receptor do tipo toll 7
TNSN07341A1 (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
GB0814302D0 (en) Compounds and methods
ATE430564T1 (de) Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
ECSP066477A (es) Composición farmacéutica que comprende ácido (2r)-2-propiloctanoico como un ingrediente activo
WO2009097443A3 (en) Liquid formulations of compounds active at sulfonylurea receptors
IL291556B1 (en) Methods and compositions for administration of arylsulfatase A to the central nervous system
BRPI0418474A (pt) solução aquosa parenteral estável
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
HUP0202749A2 (hu) Levoszimendánt tartalmazó oldat formájú gyógyszerkészítmény
ATE493143T1 (de) Kolloidale insluinformulierung mit langzeitwirkung und deren herstellung
PE20011223A1 (es) Composicion farmaceutica que comprende pemetrexed y un antioxidante como monotioglicerol, l-cisteina y acido tioglicolico
EP1354602A4 (en) MEDICAL COMPOSITIONS WITH DIURETIC AGENT AND IMPROVING INSULIN RESISTANCE
TW200735864A (en) Immediate release pharmaceutical formulation
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
JP3146218B2 (ja) 点眼剤
DE60016252D1 (de) Parenteral anzuwendende arzneizusammensetzungen enthaltend estramustinphosphat und aminosäure
MX2007015171A (es) Formulacion que comprende farnesil dibenzodiazepinona y un tensoactivo farmaceuticamente aceptable.
JPH075456B2 (ja) 点眼液
DE3942142A1 (de) Stabilisierung von glykosyliertem t-pa
EP4353232A3 (en) Composition comprising trabectedin and an amino acid
WO2012120337A1 (en) Aqueous paracetamol compositions and method of preparation